Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Butterfield

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Translational Andrology and Urology|January 23, 2018
Next-generation sequencing in non-muscle-invasive bladder cancer-a step towards personalized medicine for a superficial bladder tumorAndrew Butterfield, Sumati Gupta
BMC Bioinformatics|January 7, 2004
PyEvolve: a toolkit for statistical modelling of molecular evolutionAndrew Butterfield, Vivek Vedagiri, Edward Lang, et al.
Cancer & Metabolism|December 9, 2020
Protein synthesis inhibitors stimulate MondoA transcriptional activity by driving an accumulation of glucose 6-phosphateBlake R Wilde, Mohan R Kaadige, Katrin P Guillen, et al.
Oncotarget|March 9, 2018
Reversible LSD1 inhibition with HCI-2509 induces the p53 gene expression signature and disrupts the MYCN signature in high-risk neuroblastoma cellsSumati Gupta, Kelly Doyle, Timothy L Mosbruger, et al.
Communications Biology|August 8, 2022
Multiparametric quantitative phase imaging for real-time, single cell, drug screening in breast cancerEdward R Polanco, Tarek E Moustafa, Andrew Butterfield, et al.
Molecular Cancer Therapeutics|October 11, 2018
Histone Deacetylase Inhibition Has Targeted Clinical Benefit in <i>ARID1A</i>-Mutated Advanced Urothelial CarcinomaSumati Gupta, Daniel J Albertson, Timothy J Parnell, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Translational Andrology and Urology|January 23, 2018
Next-generation sequencing in non-muscle-invasive bladder cancer-a step towards personalized medicine for a superficial bladder tumorAndrew Butterfield, Sumati Gupta
BMC Bioinformatics|January 7, 2004
PyEvolve: a toolkit for statistical modelling of molecular evolutionAndrew Butterfield, Vivek Vedagiri, Edward Lang, et al.
Cancer & Metabolism|December 9, 2020
Protein synthesis inhibitors stimulate MondoA transcriptional activity by driving an accumulation of glucose 6-phosphateBlake R Wilde, Mohan R Kaadige, Katrin P Guillen, et al.
Oncotarget|March 9, 2018
Reversible LSD1 inhibition with HCI-2509 induces the p53 gene expression signature and disrupts the MYCN signature in high-risk neuroblastoma cellsSumati Gupta, Kelly Doyle, Timothy L Mosbruger, et al.
Communications Biology|August 8, 2022
Multiparametric quantitative phase imaging for real-time, single cell, drug screening in breast cancerEdward R Polanco, Tarek E Moustafa, Andrew Butterfield, et al.
Molecular Cancer Therapeutics|October 11, 2018
Histone Deacetylase Inhibition Has Targeted Clinical Benefit in <i>ARID1A</i>-Mutated Advanced Urothelial CarcinomaSumati Gupta, Daniel J Albertson, Timothy J Parnell, et al.
Pageof 1